RTW Investments, LP 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
RTW Investments, LP | 1,024,335 9.990% |
-8,196,337 (-88.89%) |
Filing |
| 2024-02-14 07:02 am Purchase |
2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS |
RTW Investments, LP | 9,220,672 9.990% |
9,220,672 (New Position) |
Filing |